- Correction
- Open access
- Published:
Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a
Journal of Hematology & Oncology volume 11, Article number: 56 (2018)
The original article [1] contains an error in Fig. 5a whereby the Western blot bands representing CyclinD1 have mistakenly been duplicated over the Western blot bands intended to represent SGK.
As such, the correct version of Fig. 5a with the correct representation of the Western blots of SGK can be seen ahead.
Reference
Cao M-Q, et al. miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a. J Hematol Oncol. 2018;11:12.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Cao, MQ., You, AB., Zhu, XD. et al. Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a. J Hematol Oncol 11, 56 (2018). https://doi.org/10.1186/s13045-018-0599-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s13045-018-0599-z